Filing Details
- Accession Number:
- 0001645627-17-000066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-22 13:10:22
- Reporting Period:
- 2017-05-18
- Filing Date:
- 2017-05-22
- Accepted Time:
- 2017-05-22 13:10:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,847,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,848,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,849,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,850,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,851,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,852,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,853,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,854,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,855,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,856,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,857,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,858,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,859,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,860,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,861,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,862,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.05 | 20,863,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,864,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,865,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,866,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,867,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,868,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,869,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,870,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,871,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,872,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,873,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,874,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,875,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-18 | 1,000 | $0.06 | 20,876,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
